Xtant Medical Holdings (XTNT) Other financing activities (2010 - 2021)
Xtant Medical Holdings' (XTNT) quarterly Other financing activities came in at $104000.0 in Q3 2021, up 100.57% on a QoQ basis from -$18.4 million in Q2 2021.
Xtant Medical Holdings (XTNT) Other financing activities (2010 - 2021) Analysis & Trends
Xtant Medical Holdings (XTNT) has 6 years of Other financing activities data on file, last reported at $104000.0 in Q3 2021.
- On a quarterly basis, Other financing activities changed N/A year-over-year to $104000.0 in Q3 2021; TTM through Dec 2024 was $104000.0, a 100.57% increase from a year earlier, with the FY2024 full-year figure at $4.5 million, down 68.2% from the prior year.
- Other financing activities for Q3 2021 stood at $104000.0, up from -$18.4 million in the prior quarter.
- Over the last five years, Other financing activities for XTNT reached as high as $18.4 million in Q1 2021 and fell as low as -$18.4 million in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Xtant Medical Holdings | 5.69 Mn | -11.63 Mn | 17.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 104,000.00 |
| Sep 30, 2021 | 104,000.00 |
| Jun 30, 2021 | -18.39 Mn |
| Jun 30, 2021 | -18.39 Mn |
| Mar 31, 2021 | 18.43 Mn |
| Mar 31, 2021 | 18.43 Mn |
| Dec 31, 2015 | -503,895.00 |
| Dec 31, 2015 | -503,895.00 |
| Sep 30, 2013 | 27,575.00 |
| Sep 30, 2013 | 27,575.00 |
| Dec 31, 2012 | 2,669.00 |
| Dec 31, 2012 | 2,669.00 |
| Sep 30, 2012 | 23,235.00 |
| Sep 30, 2012 | 23,235.00 |
| Mar 31, 2012 | 20,099.00 |
| Mar 31, 2012 | 20,099.00 |
| Dec 31, 2011 | -308,871.00 |
| Dec 31, 2011 | -308,871.00 |
| Sep 30, 2011 | 625,076.00 |
| Sep 30, 2011 | 625,076.00 |